Does Vitamin D improve markers of vascular health in stroke patients?

Phase 1

• Conditions: Stroke (Ischaemic and haemorrhagic); MedDRA version: 9.1Level: LLTClassification code 10023027Term: Ischaemic stroke NOS; MedDRA version: 9.1Level: LLTClassification code 10048863Term: Hemorrhagic stroke

• Registration Number: EUCTR2007-001324-13-GB
• Lead Sponsor: Research and Innovation Services, University of Dundee

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-05-16
• Last Update Posted: 3 April 2017

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Clinical diagnosis of completed stroke (ischaemic or haemorrhagic)
Serum 25 hydroxy Vitamin D level of <50nmol/L

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Hyper- or hypocalcaemia (calcium <2.15mmol/L or >2.60 mmol/L
Metastatic malignancy
LFTs > 3x upper limit of normal
Estimated GFR <40ml/min
Previous clinical diagnosis of osteomalacia
Taking vitamin D preparations
Unable to give written informed consent
Unable to swallow tablets orally
Atrial fibrillation

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified